BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 1657912)

  • 1. Effects of a novel lanosterol 14 alpha-demethylase inhibitor on the regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase in Hep G2 cells.
    Mayer RJ; Adams JL; Bossard MJ; Berkhout TA
    J Biol Chem; 1991 Oct; 266(30):20070-8. PubMed ID: 1657912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase in human hepatoma cell line Hep G2. Effects of inhibitors of cholesterol synthesis on enzyme activity.
    Boogaard A; Griffioen M; Cohen LH
    Biochem J; 1987 Jan; 241(2):345-51. PubMed ID: 3036060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of hepatic cholesterol biosynthesis. Effects of a cytochrome P-450 inhibitor on the formation and metabolism of oxygenated sterol products of lanosterol.
    Iglesias J; Gibbons GF
    Biochem J; 1989 Dec; 264(2):495-502. PubMed ID: 2604729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lanosterol analogs: dual-action inhibitors of cholesterol biosynthesis.
    Frye LL; Leonard DA
    Crit Rev Biochem Mol Biol; 1999; 34(2):123-40. PubMed ID: 10333389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxolanosterol oximes: dual-action inhibitors of cholesterol biosynthesis.
    Frye LL; Cusack KP; Leonard DA; Anderson JA
    J Lipid Res; 1994 Aug; 35(8):1333-44. PubMed ID: 7989858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of 19-oxygenated lanosterol derivatives on 3-hydroxy-3-methylglutaryl coenzyme a reductase activity and lanosterol demethylase activity.
    Sonoda Y; Suzuki S; Udagawa K; Ota K; Tasaka R; Fukamachi Y; Sato Y
    Biol Pharm Bull; 1996 Jan; 19(1):57-61. PubMed ID: 8820912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of 3-hydroxy-3-methylglutaryl-CoA reductase by 15 alpha-fluorolanost-7-en-3 beta-ol. A mechanism-based inhibitor of cholesterol biosynthesis.
    Trzaskos JM; Magolda RL; Favata MF; Fischer RT; Johnson PR; Chen HW; Ko SS; Leonard DA; Gaylor JL
    J Biol Chem; 1993 Oct; 268(30):22591-9. PubMed ID: 7693673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of regulatory oxysterol formation and low density lipoprotein suppression of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase activity by ketoconazole. A role for cytochrome P-450 in the regulation of HMG-CoA reductase in rat intestinal epithelial cells.
    Gupta A; Sexton RC; Rudney H
    J Biol Chem; 1986 Jun; 261(18):8348-56. PubMed ID: 3722155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The novel cholesterol-lowering drug SR-12813 inhibits cholesterol synthesis via an increased degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase.
    Berkhout TA; Simon HM; Patel DD; Bentzen C; Niesor E; Jackson B; Suckling KE
    J Biol Chem; 1996 Jun; 271(24):14376-82. PubMed ID: 8662919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of 3-hydroxy-3-methylglutaryl-CoA reductase mRNA contents in human hepatoma cell line Hep G2 by distinct classes of mevalonate-derived metabolites.
    Cohen LH; Griffioen M
    Biochem J; 1988 Oct; 255(1):61-7. PubMed ID: 2848511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of squalene synthetase in human hepatoma cell line Hep G2 by sterols, and not by mevalonate-derived non-sterols.
    Cohen LH; van Miert E; Griffioen M
    Biochim Biophys Acta; 1989 Mar; 1002(1):69-73. PubMed ID: 2538145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Posttranscriptional regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in lens epithelial cells by mevalonate-derived nonsterols.
    Cenedella RJ
    Exp Eye Res; 1997 Jul; 65(1):63-72. PubMed ID: 9237866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 15-substituted lanosterols: post-transcriptional suppressors of 3-hydroxy-3-methylglutaryl coenzyme A reductase.
    Anderson JA; Leonard DA; Cusack KP; Frye LL
    Arch Biochem Biophys; 1995 Jan; 316(1):190-6. PubMed ID: 7840615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a novel squalene epoxidase inhibitor, NB-598, on the regulation of cholesterol metabolism in Hep G2 cells.
    Hidaka Y; Hotta H; Nagata Y; Iwasawa Y; Horie M; Kamei T
    J Biol Chem; 1991 Jul; 266(20):13171-7. PubMed ID: 1649182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Azalanstat (RS-21607), a lanosterol 14 alpha-demethylase inhibitor with cholesterol-lowering activity.
    Burton PM; Swinney DC; Heller R; Dunlap B; Chiou M; Malonzo E; Haller J; Walker KA; Salari A; Murakami S
    Biochem Pharmacol; 1995 Aug; 50(4):529-44. PubMed ID: 7646560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In situ accumulation of 3 beta-hydroxylanost-8-en-32-aldehyde in hepatocyte cultures. A putative regulator of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity.
    Trzaskos JM; Favata MF; Fischer RT; Stam SH
    J Biol Chem; 1987 Sep; 262(25):12261-8. PubMed ID: 3624256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-transcriptional regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase by 3 beta-hydroxy-lanost-8-en-32-al, an intermediate in the conversion of lanosterol to cholesterol.
    Leonard DA; Kotarski MA; Tessiatore JE; Favata MF; Trzaskos JM
    Arch Biochem Biophys; 1994 Apr; 310(1):152-7. PubMed ID: 8161198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pravastatin inhibited the cholesterol synthesis in human hepatoma cell line Hep G2 less than simvastatin and lovastatin, which is reflected in the upregulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase and squalene synthase.
    Cohen LH; van Vliet A; Roodenburg L; Jansen LM; Griffioen M
    Biochem Pharmacol; 1993 Jun; 45(11):2203-8. PubMed ID: 8517861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tocotrienols regulate cholesterol production in mammalian cells by post-transcriptional suppression of 3-hydroxy-3-methylglutaryl-coenzyme A reductase.
    Parker RA; Pearce BC; Clark RW; Gordon DA; Wright JJ
    J Biol Chem; 1993 May; 268(15):11230-8. PubMed ID: 8388388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of compactin, mevalonate and low-density lipoprotein on 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity and low-density-lipoprotein-receptor activity in the human hepatoma cell line Hep G2.
    Cohen LH; Griffioen M; Havekes L; Schouten D; van Hinsbergh V; Kempen HJ
    Biochem J; 1984 Aug; 222(1):35-9. PubMed ID: 6089762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.